243
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Expression of vascular endothelial growth factor receptors and their ligands in rat uterus during the postpartum involution period

, &
Pages 361-374 | Accepted 11 Jan 2015, Published online: 24 Mar 2015

References

  • Alan E, Liman N (2012) Immunohistochemical localization of beta defensins in the endometrium of rat uterus during the postpartum involution period. Vet. Res. Commun. 36: 173–185.
  • Alvarez-Arroyo MV, Caramelo C, Angeles-Castilla M, Gonzalez-Pacheco FR, Martin O, Arias J (1998) Role of vascular endothelial growth factor in the response to vessel injury. Kidney Int. 68: 7–9.
  • Chew LJ, Pan H, Yu J, Tian S, Huang WQ, Zhang JY, Pang S, Li LY (2002) A novel secreted splice variant of vascular endothelial cell growth inhibitor. FASEB J. 16: 742–744.
  • De Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT (1992) The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255: 989–991.
  • Dixon D, He H, Haseman JK (2000) Immunohistochemical localization of growth factors and their receptors in uterine leiomyomas and matched myometrium. Env. Health Perspec. 108: 795–802.
  • Donoghue JF, Lederman FL, Susil BJ, Rogers PAW (2007) Lymphangiogenesis of normal endometrium and endometrial adenocarcinoma. Hum. Reprod. 22: 1705–1713.
  • Douglas NC, Tang H, Gomez R, Pytowski B, Hicklin DJ, Sauer CM, Kitajewski J, Sauer MV, Zimmermann RC (2009) Vascular endothelial growth factor receptor 2 (VEGFR-2) functions to promote uterine decidual angiogenesis during early pregnancy in the mouse. Endocrinology 150: 3845–3854.
  • Fan X, Krieg S, Kuo CJ, Wiegand SJ, Rabinovitch M, Druzin ML, Brenner RM, Giudice LC, Nayak NR (2008) VEGF blockade inhibits angiogenesis and re-epithelialization of endometrium. FASEB J. 22: 3571–3580.
  • Ferrara N (2000) Vascular endothelial growth factor and the regulation of angiogenesis. Recent Prog. Horm. Res. 55: 15–35.
  • Ferrera N (2004) VEGF: basic science and clinical progress. Endocr. Rev. 25: 581–611.
  • Graubert MD, Ortega MA, Kessel B, Mortola JF, Iruela-Arispe ML (2001) Vascular repair after menstruation ınvolves regulation of vascular endothelial growth factor-receptor phosphorylation by sFLT-1. Am. J. Pathol. 158: 1399–1410.
  • Gray CA, Stewart MD, Johnson GA, Spencer TE (2003) Postpartum uterine involution in sheep: histoarchitecture and changes in endometrial gene expression. Reproduction 125: 185–198.
  • Greb RR, Heikinheimo O, Williams RF, Hodgen GD, Goodman AL (1997) Vascular endothelial growth factor in primate endometrium is regulated by oestrogen-receptor and progesterone- receptor ligands in vivo. Hum. Reprod. 12: 1280–1292.
  • Harrison WM, Sharkey AM, Charnock JD, Smith SK (1995) Localization and quantification of vascular endothelial growth factor messenger ribonucleic acid in human myometrium and leiomyomata. J. Clin. Endocrinol. Metab. 80: 1853–1858.
  • Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo K (1996) A novel vascular endothelial growth factor, VEGF-C, is the ligand for the Flt-4 receptor tyrosine kinase (VEGFR-3). EMBO J. 15: 290–298.
  • Kendall RL, Wang G, Thomas KA (1996) Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. Biochem. Biophys. Res. Commun. 226: 324–328.
  • Kuroki M, Voest EE, Amano S, Beerepoot LV, Takashima S, Tolentino M, Kim RY, Rohan RM, Colby KA, Yeo KT, Adamis AP (1996) Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J. Clin. Invest. 98: 1667–1675.
  • Malamitsi-Puchner A, Sarandakou A, Tziotis J, Stavreus-Evers A, Tzonou A, Landgren BM (2004) Circulating angiogenic factors during periovulation and the luteal phase of normal menstrual cycles. Fertil. Steril. 81: 1322–1327.
  • Meduri G, Bausero P, Perrot-Applanat M (2000) Expression of vascular endothelial growth factor receptors in the human endometrium: modulation during the menstrual cycle. Biol. Reprod. 62: 439–447.
  • Millauer B, Wizigmann-Voos S, Schnürch H, Martinez R, Møller NP, Risau W, Ullrich A (1993) High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72: 835–846.
  • Mudduwa LKB (2009) Quick score of hormone receptor status of breast carcinoma: correlation with the other clinicopathological prognostic parameters. Ind. J. Pathol. Microbiol. 52: 159–163.
  • Nayak NR, Brenner RM (2002) Vascular proliferation and vascular endothelial growth factor expression in the rhesus macaque endometrium. J. Clin. Endocrinol. Metab. 87: 1845–1855.
  • Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L (2006) VEGF receptor signaling-in control of vascular function. Nat. Rev. Mol. Cell. Biol. 7: 359–371.
  • Ortega N, Hutchings H, Plouët J (1999) Signal relays in the VEGF system. Front. Biosci. 4: 141–152.
  • Peters KG, De Vries C, Williams LT (1993) Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc. Natl. Acad. Sci. USA 90: 8915–8919.
  • Popovici RM, Irwin JC, Giaccia AJ, Giudice LC (1999) Hypoxia and cAMP stimulate vascular endothelial growth factor (VEGF) in human endometrial stromal cells: potential relevance to menstruation and endometrial regeneration. J. Clin. Endocrinol. Metab. 84: 2245–2248.
  • Punyadeera C, Thijssen VL, Tchaikovski S, Kamps R, Delvoux B, Dunselman GA, de Goeij AF, Griffioen AW, Groothuis PG (2006) Expression and regulation of vascular endothelial growth factor ligands and receptors during menstruation and post-menstrual repair of human endometrium. Mol. Hum. Reprod. 12: 367–375.
  • Quinn TP, Peters KG, De Vries C, Ferrara N, Williams LT (1993) Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc. Natl. Acad. Sci. USA 90: 7533–7537.
  • Rogers PAW, Abberton KM (2003) Endometrial arteriogenesis: vascular smooth muscle cell proliferation and differentiation during the menstrual cycle and changes associated with endometrial bleeding disorders. Microsc. Res. Tech. 60: 412–419.
  • Salamonsen LA (2003) Tissue injury and repair in the female human reproductive tract. Reproduction 125: 301–311.
  • Sağsöz H, Ketani MA (2010) The role of estrogen receptors, erbB receptors, vascular endothelial growth factor and its receptors, and vascular endothelial growth inhibitor in the development of the rat mammary gland. Growth Factors 28: 379–393.
  • Sağsöz H, Liman N, Küçükaslan I, Saruhan BG (2013) Immunolocalization of vascular endothelial growth factor, its receptors (flk1/fms,flk1/KDR, flt4) and vascular endothelial growth inhibitor in the bitch uterus during the sexual cycle. Anim. Reprod. Sci. 140: 241–254.
  • Scott CA, Eckstrum KS, Bany BM (2012) Localization of C-Fos-induced growth factor (Figf) mRNA expression in the mouse uterus during ımplantation. Reprod. Syst. Sex Dis. S1:003. doi:10.4172/2161-038X.S1-003.
  • Terman BI, Dougher-Vermazen M, Carrion ME, Dimitrov D, Armellino DC, Gospodarowicz D, Böhlen P (1992) Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor. Biochem. Biophys. Res. Comm. 187: 1579–1586.
  • Villegas G, Lange-Sperandio B, Tufro A (2005) Autocrine and paracrine functions of vascular endothelial growth factor (VEGF) in renal tubular epithelial cells. Kidney Int. 67: 449–457.
  • Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, Heldin CH (1994) Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J. Biol. Chem. 269: 26988–26995.
  • Wang H, Wang B (2010) Inhibition of corneal neovascularization by vascular endothelia growth inhibitor gene. Int. J. Ophthalmol. 3: 295–298.
  • Weston G, Rogers PA (2000) Endometrial angiogenesis. Baillieres Best Pract. Res. Clin. Obstet. Gynaecol. 14: 919–936.
  • Yue TL, Ni J, Romanic AM, Gu JL, Keller P, Wang C, Kumar S, Yu GL, Hart TK, Wang X, Xia Z, De Wolf WE Jr, Feuerstein GZ (1999) TL1, a novel tumor necrosis factor-like cytokine, induces apoptosis in endothelial cells. Involvement of activation of stress protein kinases (stress-activated protein kinase and p38 mitogen-activated protein kinase) and caspase-3-like protease. J. Biol. Chem. 274: 1479–1486.
  • Zhai Y, Ni J, Jiang G, Lu J, Xing L, Lincoln C, Carter KC, Janat F, Kozak D, Xu S, Rojas L, Aggarwal BB, Ruben S, Li L, Gentz R, Yu G (1999) VEGI, a novel cytokine of the tumor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivo. FASEB J. 13: 181–189.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.